Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany A Traina

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Oncology (Williston Park, N.Y.)|May 30, 2009
Bevacizumab in the treatment of metastatic breast cancerTiffany A Traina
Annals of Surgical Oncology|August 3, 2017
The Androgen Receptor: Is It a Promising Target?Ayca Gucalp, Tiffany A Traina
Cancer Journal (Sudbury, Mass.)|February 19, 2010
Triple-negative breast cancer: role of the androgen receptorAyca Gucalp, Tiffany A Traina
Current Problems in Cancer|November 7, 2016
Targeting the androgen receptor in triple-negative breast cancerAyca Gucalp, Tiffany A Traina
Chemotherapy Research and Practice|February 8, 2012
Triple-negative breast cancer: adjuvant therapeutic optionsAyca Gucalp, Tiffany A Traina
Advances in Experimental Medicine and Biology|August 29, 2019
Emerging Novel Therapeutics in Triple-Negative Breast CancerTomas G Lyons, Tiffany A Traina
Current Opinion in Investigational Drugs (London, England : 2000)|July 10, 2004
Aromatase inhibitors for hormonal therapy of early-stage breast cancerTiffany A Traina, Maura N Dickler
Breast Cancer (Dove Medical Press)|September 2, 2014
Palbociclib: an evidence-based review of its potential in the treatment of breast cancerKaren A Cadoo, Ayca Gucalp, Tiffany A Traina
Hematology/Oncology Clinics of North America|May 22, 2007
Bevacizumab for advanced breast cancerTiffany A Traina, Hope S Rugo, Maura Dickler
Women'S Health (London, England)|July 6, 2013
The role of the androgen receptor in triple-negative breast cancerPayal D Shah, Ayca Gucalp, Tiffany A Traina
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Oncology (Williston Park, N.Y.)|May 30, 2009
Bevacizumab in the treatment of metastatic breast cancerTiffany A Traina
Annals of Surgical Oncology|August 3, 2017
The Androgen Receptor: Is It a Promising Target?Ayca Gucalp, Tiffany A Traina
Cancer Journal (Sudbury, Mass.)|February 19, 2010
Triple-negative breast cancer: role of the androgen receptorAyca Gucalp, Tiffany A Traina
Current Problems in Cancer|November 7, 2016
Targeting the androgen receptor in triple-negative breast cancerAyca Gucalp, Tiffany A Traina
Chemotherapy Research and Practice|February 8, 2012
Triple-negative breast cancer: adjuvant therapeutic optionsAyca Gucalp, Tiffany A Traina
Advances in Experimental Medicine and Biology|August 29, 2019
Emerging Novel Therapeutics in Triple-Negative Breast CancerTomas G Lyons, Tiffany A Traina
Current Opinion in Investigational Drugs (London, England : 2000)|July 10, 2004
Aromatase inhibitors for hormonal therapy of early-stage breast cancerTiffany A Traina, Maura N Dickler
Breast Cancer (Dove Medical Press)|September 2, 2014
Palbociclib: an evidence-based review of its potential in the treatment of breast cancerKaren A Cadoo, Ayca Gucalp, Tiffany A Traina
Hematology/Oncology Clinics of North America|May 22, 2007
Bevacizumab for advanced breast cancerTiffany A Traina, Hope S Rugo, Maura Dickler
Women'S Health (London, England)|July 6, 2013
The role of the androgen receptor in triple-negative breast cancerPayal D Shah, Ayca Gucalp, Tiffany A Traina
Pageof 7